Glycoside conjugation in microsomes from hepatic and renal carcinoma of manMATERN, H; FIEBIG, H.-H; MATERN, S et al.Hepatology (Baltimore, Md.). 1987, Vol 7, Num 5, pp 931-936, issn 0270-9139Article

Cytostatic anticancer drug development: preclinical studies and early clinical trials (Frankfurt/Main, November 1989)BERDEL, W. E; FIEBIG, H.-H.Journal of cancer research and clinical oncology. 1990, Vol 116, Num 2, pp 224-227, issn 0171-5216, 4 p.Article

Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusionRASSMANN, I; THÖDTMANN, R; MROSS, M et al.Investigational new drugs. 1998, Vol 16, Num 4, pp 319-324, issn 0167-6997Article

The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenograftsBREISTØL, K; HENDRIKS, H. R; BERGER, D. P et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1602-1606, issn 0959-8049Conference Paper

Alkyl and alkoxyethyl antineoplastic phospholipidsKOUFAKI, M; POLYCHRONIOU, V; CALOGEROPOULOU, T et al.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 13, pp 2609-2614, issn 0022-2623Article

Preclinical phase II studies in human tumor xenografts : a European multicenter follow-up studyLANDON, S. P; HENDRIKS, H. R; BRAAKHUIS, B.-J. M et al.Annals of oncology. 1994, Vol 5, Num 5, pp 415-422, issn 0923-7534Article

Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenograftsHENDRIKS, H. R; LANGDON, S; BERGER, D. P et al.European journal of cancer (1990). 1992, Vol 28A, Num 4-5, pp 767-773, issn 0959-8049Article

Phase II preclinical drug screening in human tumor xenografts : a first european multicenter collaborative studyBOVEN, E; WINOGRAD, B; BERGER, D. P et al.Cancer research (Baltimore). 1992, Vol 52, Num 21, pp 5940-5947, issn 0008-5472Article

Combined in vitro/in vivo test procedure with human tumor xenografts for anticancer drug developmentFIEBIG, H. H; WINTERHALTER, B; BERGER, D. P et al.Strahlentherapie und Onkologie. 1989, Vol 165, Num 7, pp 522-524, issn 0179-7158, 3 p.Article

Synthesis, mechanism of action, and biological evaluation of mitosenesORLEMANS, E. O. M; VERBOOM, W; SCHELTINGA, M. W et al.Journal of medicinal chemistry (Print). 1989, Vol 32, Num 7, pp 1612-1620, issn 0022-2623Article

Development and characterization of 51 human tumor models for large bowel, stomach and esophageal cancersFIEBIG, H. H; WIDMER, K.-H; FIEDLER, L et al.Digestive surgery. 1984, Vol 1, Num 4, pp 225-235, issn 0253-4886Article

Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivoVARVARESOU, A; IAKOVOU, K; GIKAS, E et al.Anticancer research. 2004, Vol 24, Num 2B, pp 907-919, issn 0250-7005, 13 p.Article

The antitumour activity of alkylating agents is not correlated with the levels of glutathione, glutathione transferase and O⁶-alkylguanine-DNA-alkyltransferase of human tumour xenograftsD'INCALCI, M; BONFANTI, M; PIFFERI, A et al.European journal of cancer (1990). 1998, Vol 34, Num 11, pp 1749-1755, issn 0959-8049Article

Mouse fibroblast activation protein : Molecular cloning, alternative splicing and expression in the reactive stroma of epithelial cancersNIEDERMEYER, J; SCANLAN, M. J; GARIN-CHESA, P et al.International journal of cancer. 1997, Vol 71, Num 3, pp 383-389, issn 0020-7136Article

Synthesis of new maleimide derivatives of daunorubicin and biological activity of acid labile transferrin conjugatesKRATZ, F; BEYER, U; SCHUMACHER, P et al.Bioorganic & medicinal chemistry letters (Print). 1997, Vol 7, Num 5, pp 617-622, issn 0960-894XArticle

EO9 : a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical modelsHENDRIKS, H. R; PIZAO, P. E; HORNSTRA, H. W et al.European journal of cancer. Part A. 1993, Vol 29, Num 6, pp 897-906Article

Detection of monosomy in interphase nuclei and identification of marker chromosomes using biotinylated alpha-satellite DNA probesKIECHLE-SCHWARZ, M; DECKER, H.-J. H; BERGER, C. S et al.Cancer genetics and cytogenetics. 1991, Vol 51, Num 1, pp 23-33, issn 0165-4608, 11 p.Article

Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumor efficacySCHWENDENER, R. A; FIEBIG, H. H; BERGER, M. R et al.Cancer chemotherapy and pharmacology. 1991, Vol 27, Num 6, pp 429-439, issn 0344-5704, 11 p.Article

Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by quercetinHOFMANN, J; FIEBIG, H. H; WINTERHALTER, B. R et al.International journal of cancer. 1990, Vol 45, Num 3, pp 536-539, issn 0020-7136Article

CGP 6809 ― A new nitrosoureido-sugar derivative with activity in human tumor xenograftsFIEBIG, H. H; WIDMER, K. H; WINTERHALTER, B. R et al.Cancer chemotherapy and pharmacology. 1989, Vol 23, Num 6, pp 337-340, issn 0344-5704Article

Clonal growth of human tumor scenografts: first experiences in drug testingHENSS, H; FIEBIG, H. H; MEINHARDT, K et al.Journal of cancer research and clinical oncology. 1984, Vol 108, Num 2, pp 233-235, issn 0171-5216Article

Fractionated irradiation under ambient conditions of human NSCLC transplanted into nude mice: effect of different fractionation schedules and of radiotherapy and vindesineHINKELBEIN, W; WALLBRECHER, E; FIEBIG, H. H et al.Strahlentherapie und Onkologie. 1989, Vol 165, Num 7, pp 519-520, issn 0179-7158Article

Preclinical pharmacology of the pyrrolobenzodiazepine (PBD) monomer DRH-417 (NSC 709119)BURGER, A. M; LOADMAN, P. M; THURSTON, D. E et al.Journal of chemotherapy. 2007, Vol 19, Num 1, pp 66-78, issn 1120-009X, 13 p.Article

BBR 3464 : A novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatinMANZOTTI, C; PRATESI, G; PEZZONI, G et al.Clinical cancer research. 2000, Vol 6, Num 7, pp 2626-2634, issn 1078-0432Article

Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patientsHARTUNG, G; STEHLE, G; HEENE, D. L et al.Clinical cancer research. 1999, Vol 5, Num 4, pp 753-759, issn 1078-0432Article